MBL2 and Stroke: Among 135 patients who had suffered a stroke, those with MBL-sufficient genotypes and high-circulating MBL levels had a 10.85-fold increased risk of adverse outcome at 3 months than individuals carrying MBL-low genotypes (p = 0.008) (39, 40).